MTHFR & Methylation Support Guide

Methylation is one of the most fundamental biochemical processes in human physiology — involved in DNA repair, neurotransmitter production, detoxification, immune regulation, and gene expression. For functional nutritionists, understanding methylation — and the genetic variants that can impair it — is increasingly central to clinical practice.

This guide covers the core methylation pathway, the most clinically relevant genetic SNPs including MTHFR, and practical nutritional support strategies practitioners use to address methylation dysfunction.

The Methylation Cycle: A Clinical Overview

Methylation is the transfer of a methyl group (CH₃) to a molecule, which activates or deactivates biological processes. The methionine cycle and folate cycle are the two primary methylation pathways, and they are interdependent.

The key process: dietary folate is converted through a series of enzymatic steps into 5-methyltetrahydrofolate (5-MTHF), the active form. 5-MTHF then donates its methyl group to homocysteine, converting it to methionine — the precursor to S-adenosyl methionine (SAM). SAM is the universal methyl donor used in 200+ enzymatic reactions in the body.

When this cycle is disrupted — by genetic variants, nutrient deficiencies, toxin burden, or chronic stress — homocysteine accumulates and SAM production drops. Elevated homocysteine is a cardiovascular risk marker and is associated with neurological dysfunction, recurrent miscarriage, and elevated systemic inflammation.

MTHFR: The Most Common Methylation SNP

MTHFR (methylenetetrahydrofolate reductase) encodes the enzyme that converts 5,10-methylenetetrahydrofolate to 5-MTHF. Two variants are clinically relevant:

B12 and Folate: The Critical Co-factors

Folate — Active Form Matters

Standard folic acid (the synthetic form in most supplements and fortified foods) must be converted to 5-MTHF through the very pathway MTHFR variants impair. For individuals with significant MTHFR variants, high-dose folic acid supplementation can actually accumulate as unmetabolized folic acid (UMFA), which may have immune and cognitive implications.

The clinical approach: use methylfolate (L-5-MTHF) in supplementation — bypassing the impaired enzymatic step. Standard doses range from 400–1000 mcg for C677T heterozygous individuals, with homozygous cases sometimes requiring higher doses under clinical supervision.

B12 — Methylcobalamin vs Cyanocobalamin

Methylcobalamin is the active, methylated form of B12 that participates directly in the methionine cycle. Cyanocobalamin (the synthetic form in most supplements) requires conversion to methylcobalamin. For impaired methylation capacity, methylcobalamin or hydroxocobalamin are preferred supplemental forms.

B12 deficiency is also often underdiagnosed because serum B12 measures total B12, not functional B12. Methylmalonic acid (MMA) and homocysteine are more sensitive functional markers — elevated MMA indicates B12 insufficiency even when serum B12 appears normal.

Other Clinically Relevant Methylation SNPs

• COMT (Val158Met): Affects catecholamine breakdown (dopamine, epinephrine, estrogen). Slow COMT (Val/Val) is associated with estrogen dominance, anxiety, and difficulty clearing catecholamines. Methyl group availability affects COMT activity — over-methylation can accelerate breakdown too aggressively in fast COMT individuals.
• MTRR (A66G): Affects methionine synthase reductase, which regenerates active B12. Variants here increase B12 demand and can compound MTHFR effects.
• CBS (C699T): Affects the transsulfuration pathway — the exit ramp from the methylation cycle into glutathione and sulfur amino acid metabolism. CBS upregulation can drain the methionine cycle, increasing homocysteine turnover and reducing SAM availability.
• BHMT: The betaine-homocysteine methyltransferase pathway provides an alternative route to convert homocysteine to methionine, bypassing the folate cycle. Trimethylglycine (betaine) supplementation supports this backup pathway.

Supplement Protocols for Methylation Support

Methylation support should be individualized based on SNP profile, lab markers (homocysteine, MMA, serum B12, RBC folate), and symptom presentation. A general support framework:

• L-5-MTHF: 400–1000 mcg/day (start low, increase based on tolerance)
• Methylcobalamin: 500–1000 mcg/day
• B6 (as P5P): Supports transsulfuration and GABA synthesis
• Riboflavin (B2): Co-factor for MTHFR enzyme function; often deficient in those with MTHFR C677T
• Trimethylglycine (betaine): Supports the BHMT bypass pathway; particularly useful for CBS variants
• Magnesium: Required cofactor for multiple methylation-cycle enzymes; frequently depleted
• Zinc: Supports methionine synthase and overall methylation capacity

Testing Methylation Status

SNP genetic testing is widely accessible but is only part of the picture. Functional lab markers are essential to understanding actual methylation status:

• Homocysteine: Optimal range is 6–8 µmol/L. Elevated homocysteine (>12) indicates impaired remethylation or increased demand.
• RBC folate: Reflects tissue folate stores; more clinically relevant than serum folate.
• Serum B12 + MMA: Serum B12 above 500 pg/mL with normal MMA suggests adequate functional B12.
• SAM/SAH ratio: Available through specialty labs; reflects the methylation potential of the cell. A low ratio indicates undermethylation.
• Organic acids testing: Elevated methylmalonic acid on OAT confirms functional B12 insufficiency.

Methylation is rarely an isolated issue in clinical practice. It intersects with gut health (B12 absorption requires intrinsic factor and adequate stomach acid), hormone metabolism (COMT and estrogen), detoxification (glutathione synthesis via transsulfuration), and neurological function. Understanding these intersections is what separates protocol-level functional nutrition from systems-level functional nutrition.